Great Lakes Retirement Inc. Invests $551,000 in Maximus, Inc. (NYSE:MMS)

Great Lakes Retirement Inc. purchased a new stake in Maximus, Inc. (NYSE:MMSFree Report) during the 4th quarter, Holdings Channel.com reports. The institutional investor purchased 6,565 shares of the health services provider’s stock, valued at approximately $551,000.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. VisionPoint Advisory Group LLC boosted its position in shares of Maximus by 61.4% during the 3rd quarter. VisionPoint Advisory Group LLC now owns 381 shares of the health services provider’s stock worth $28,000 after purchasing an additional 145 shares in the last quarter. Farther Finance Advisors LLC lifted its stake in Maximus by 71.7% during the 2nd quarter. Farther Finance Advisors LLC now owns 352 shares of the health services provider’s stock valued at $30,000 after acquiring an additional 147 shares in the last quarter. Metropolitan Life Insurance Co NY raised its holdings in shares of Maximus by 4.4% in the fourth quarter. Metropolitan Life Insurance Co NY now owns 3,813 shares of the health services provider’s stock valued at $280,000 after purchasing an additional 162 shares during the last quarter. Captrust Financial Advisors boosted its holdings in Maximus by 14.9% during the second quarter. Captrust Financial Advisors now owns 1,303 shares of the health services provider’s stock worth $81,000 after purchasing an additional 169 shares during the last quarter. Finally, Cetera Investment Advisers grew its position in Maximus by 4.5% in the 1st quarter. Cetera Investment Advisers now owns 4,253 shares of the health services provider’s stock worth $319,000 after purchasing an additional 184 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Price Performance

Shares of NYSE MMS traded up $0.54 during midday trading on Thursday, hitting $84.03. 213,819 shares of the company’s stock were exchanged, compared to its average volume of 359,261. Maximus, Inc. has a 12-month low of $72.39 and a 12-month high of $89.69. The company has a market cap of $5.13 billion, a price-to-earnings ratio of 27.97 and a beta of 0.73. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.71. The business’s fifty day moving average price is $82.88 and its two-hundred day moving average price is $80.67.

Maximus (NYSE:MMSGet Free Report) last posted its quarterly earnings data on Wednesday, February 7th. The health services provider reported $1.34 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.06. Maximus had a net margin of 3.73% and a return on equity of 15.68%. The firm had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.29 billion. During the same quarter last year, the company posted $0.94 EPS. The business’s quarterly revenue was up 6.2% on a year-over-year basis. As a group, research analysts forecast that Maximus, Inc. will post 5.41 EPS for the current fiscal year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, February 29th. Stockholders of record on Thursday, February 15th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.43%. The ex-dividend date was Wednesday, February 14th. Maximus’s dividend payout ratio is 39.74%.

Insider Transactions at Maximus

In related news, CFO David Mutryn sold 8,000 shares of Maximus stock in a transaction on Friday, February 16th. The shares were sold at an average price of $83.95, for a total value of $671,600.00. Following the sale, the chief financial officer now owns 5,124 shares in the company, valued at $430,159.80. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.40% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on MMS. Raymond James downgraded shares of Maximus from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 3rd. TheStreet upgraded Maximus from a “c+” rating to a “b-” rating in a research report on Monday, December 4th. Finally, StockNews.com raised Maximus from a “hold” rating to a “buy” rating in a report on Thursday, February 8th.

Get Our Latest Research Report on MMS

About Maximus

(Free Report)

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.

Recommended Stories

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMSFree Report).

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.